My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

59 60 Next >

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows ↗

November 11, 2022

Via Benzinga

AstraZeneca PLC (AZN) Q3 2022 Earnings Call Transcript ↗

November 10, 2022

AZN earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why AstraZeneca Stock Shot Higher Today ↗

November 10, 2022

The company trounced analyst profitability estimates for its latest quarter and raised its guidance.

Via The Motley Fool

AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth ↗

November 10, 2022

Excluding exchange rates, AstraZeneca's sales surged 19% and came in above forecasts.

Via Investor's Business Daily

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11 ↗

November 10, 2022

Bloomberg

Via Benzinga

Why Are Apellis Pharmaceuticals Shares Falling Today? ↗

November 04, 2022

Via Benzinga

Why Horizon Therapeutics' Shares Rose 11.32% on Wednesday ↗

November 02, 2022

The company released encouraging year-end guidance.

Via The Motley Fool

Apple Hires Facebook Veteran as Information Chief; More Departures Likely ↗

November 10, 2022

Via Benzinga

Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks ↗

November 10, 2022

These stocks both pay more than 2% per year in dividends.

Via The Motley Fool

AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength ↗

November 10, 2022

Via Benzinga

'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target ↗

November 09, 2022

Via Benzinga

FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids ↗

November 09, 2022

Via Benzinga

Options Traders Expect AstraZeneca Shares To Fall After Earnings Report, As Stock Is Up 5% In 2022 ↗

November 09, 2022

On CNBC's "Options Action," Michael Khouw of Optimize Advisors said that AstraZeneca plc. (NASDAQ: AZN) traded 3.9 times its average daily put volume on Tuesday.

Via Benzinga

Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants ↗

November 04, 2022

Via Benzinga

Sorrento Has Potential To Deliver Multiple Best-In-Class Products ↗

November 02, 2022

Via Benzinga

Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends. ↗

November 01, 2022

As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends.

Via InvestorPlace

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know ↗

November 01, 2022

October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...

Via Benzinga

European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine ↗

November 01, 2022

Via Benzinga

15 Global Psychedelics Executives To Keep An Eye On In 2022 ↗

October 28, 2022

As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list...

Via Benzinga

Why Invitae Stock Was So Healthy This Week ↗

October 28, 2022

Even though the genetics testing specialist didn't divulge the financial details of a new partnership, investors nevertheless were happpy about the news.

Via The Motley Fool

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest ↗

October 28, 2022

Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point.

Via InvestorPlace

3 Perfect Stocks Retirees Can Buy Hand Over Fist Right Now ↗

October 28, 2022

Bargains abound for seniors who want steady long-term appreciation potential.

Via The Motley Fool

AstraZeneca's Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain, Spinal Cord ↗

October 27, 2022

Via Benzinga

A New BioTech Research Race Is Focused On Improving Life For MS Patients ↗

October 27, 2022

When the world is focused on a global pandemic no one saw coming four years ago, the attention given to escalating diseases with no known cure can be hidden from the public consciousness. This is...

Via Benzinga

Intel's Self-Driving Tech Firm Raises Over $800M In IPO, Alphabet Misses Q3 Earnings Expectations, Lyft Cuts Price For Monthly Subscription Plan: Top Stories Wednesday, Oct. 26 ↗

October 26, 2022

Benzinga

Via Benzinga

AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings ↗

October 26, 2022

Via Benzinga

Cytokinetics CEO: Why It's OK Not Being An Overnight Success ↗

October 25, 2022

The company hopes to come out next year with at least one heart-failure drug.

Via Investor's Business Daily

Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25 ↗

October 25, 2022

Benzinga

Via Benzinga

October 25, 2022

Via The Motley Fool

AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation ↗

October 25, 2022

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.